scispace - formally typeset
M

Maria A. Rocca

Researcher at Vita-Salute San Raffaele University

Publications -  647
Citations -  29881

Maria A. Rocca is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Multiple sclerosis & Magnetic resonance imaging. The author has an hindex of 83, co-authored 556 publications receiving 25283 citations. Previous affiliations of Maria A. Rocca include University at Buffalo & Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Multiple sclerosis: Monitoring long-term treatments in multiple sclerosis

Massimo Filippi, +1 more
- 01 Aug 2010 - 
TL;DR: Patients with relapsing-remitting multiple sclerosis have been shown to benefit from disease-modifying treatments over prolonged periods, and more focus should now be placed on monitoring the long-term evolution of this disease, alongside the patients' response and adherence to such treatments.
Journal ArticleDOI

Demyelination and cortical reorganization: functional MRI data from a case of subacute combined degeneration.

Massimo Filippi, +6 more
- 01 Feb 2003 - 
TL;DR: This multiparametric magnetic resonance study of a patient with an early diagnosis of subacute combined degeneration suggests that demyelination alone does not necessarily induce adaptive functional changes of the cerebral cortex.
Journal ArticleDOI

Effects on cognition of DMTs in multiple sclerosis: moving beyond the prevention of inflammatory activity.

Paolo Preziosa, +3 more
- 07 Oct 2021 - 
TL;DR: In this paper, a review of recent findings derived from randomized controlled trials (RCTs), observational studies and meta-analyses that have been published in the last 3 years and that included the effects of DMTs on cognitive performances among their outcomes is presented.
Journal ArticleDOI

The association between cognition and motor performance is beyond structural damage in relapsing–remitting multiple sclerosis

Damiano Mistri, +6 more
- 12 Mar 2022 - 
TL;DR: In RRMS patients, deficit in information processing speed and executive function may contribute to hand motor dysfunction beyond the effect of structural disease-related burden, supporting the integration of motor and cognitive assessment in clinical settings.
Journal ArticleDOI

Siponimod for Cognition in Secondary Progressive Multiple Sclerosis: Thinking Through the Evidence

Victoria M. Leavitt, +1 more
- 19 Jan 2021 - 
TL;DR: A recent meta-analysis assessing the benefits of DMTs for cognition in relapsing-remitting MS found a small improvement across 44 studies included as mentioned in this paper, however, there has been very little work evaluating the benefits for DMT-based treatments in progressive MS.